FEATURE: Genomics Sector Shows Renewed Vigor, but Will it Last? | GenomeWeb

NEW YORK, May 23 – Genomics stocks, many of which hit new lows at the end of March or beginning of April, appear to be gaining momentum, pulled higher by the market's overall rise and renewed investor confidence following the Internet crash, analysts said Wednesday.

“Total stock is up,” said Winton Gibbons, a analyst at William Blair of Chicago. But he noted that people are also separating genome stocks out from the negative association with Internet stocks.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.